SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-036719
Filing Date
2021-03-16
Accepted
2021-03-16 08:52:55
Documents
1
Period of Report
2021-03-15

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4600
  Complete submission text file 0001104659-21-036719.txt   6860
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39067 | Film No.: 21743908
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
AstraZeneca UK LTD (Reporting) CIK: 0001362825 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39067 | Film No.: 21743907

Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Issuer) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations